Business Description
Cartesian Therapeutics is a clinical-stage company developing cell-based treatments for autoimmune diseases and certain cancers. Its furthest-along therapy, Descartes-08, uses a patient's own immune cells to target a specific protein linked to immune system problems, and is currently being tested in patients with conditions such as myasthenia gravis, lupus, and a rare childhood disease. The company is also running early-stage trials for Descartes-15, a similar treatment aimed at multiple myeloma. Cartesian operates out of Frederick, Maryland.
